On March 5, 2019 CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on our Probody therapeutic technology platform, reported that members of its senior management team will participate at the following healthcare conferences in March (Press release, CytomX Therapeutics, MAR 5, 2019, View Source [SID1234533994]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 39th Annual Health Care Conference

Date: Monday, March 11, 2019
Time: 1:30 p.m. – 2:00 p.m. EST
Location: Boston, Massachusetts

Barclays Global Healthcare Conference

Date: Tuesday, March 12, 2019
Time: 2:05 p.m. – 2:35 p.m. EST
Location: Miami, Florida

Live audio webcast of theses presentations will be available through the "Investors & News" section of CytomX’s website. An archived replay will be available for 90 days following the event.